Citation: | Huihui Xu, Zhiwen Fan, Wenfang Tian, Yong Xu. Protein inhibitor of activated STAT 4 (PIAS4) regulates liver fibrosis through modulating SMAD3 activity[J]. The Journal of Biomedical Research, 2016, 30(6): 496-501. DOI: 10.7555/JBR.30.20160049 |
[1] | Anastasia V. Poznyak, Alexey A. Yakovlev, Mikhail А. Popov, Elena B. Zhigmitova, Vasily N. Sukhorukov, Alexander N. Orekhov. Atherosclerosis originating from childhood: Specific features[J]. The Journal of Biomedical Research, 2024, 38(3): 233-240. DOI: 10.7555/JBR.37.20230198 |
[2] | Zheng Qiao, Pan Lihong, Ji Yong. H2S protects against diabetes-accelerated atherosclerosis by preventing the activation of NLRP3 inflammasome[J]. The Journal of Biomedical Research, 2020, 34(2): 94-102. DOI: 10.7555/JBR.33.20190071 |
[3] | Hiyoshi Toru, Fujiwara Mutsunori, Yao Zemin. Postprandial hyperglycemia and postprandial hypertriglyceridemia in type 2 diabetes[J]. The Journal of Biomedical Research, 2019, 33(1): 1-16. DOI: 10.7555/JBR.31.20160164 |
[4] | Kaibo Lin, Shikun Zhang, Jieli Chen, Ding Yang, Mengyi Zhu, Eugene Yujun Xu. Generation and functional characterization of a conditional Pumilio2 null allele[J]. The Journal of Biomedical Research, 2018, 32(6): 434-441. DOI: 10.7555/JBR.32.20170117 |
[5] | Mingming Gao, Guo Xin, Xu Qiu, Yuhui Wang, George Liu. Establishment of a rat model with diet-induced coronary atherosclerosis[J]. The Journal of Biomedical Research, 2017, 31(1): 47-55. DOI: 10.7555/JBR.31.20160020 |
[6] | Hui Liang, Wei Guan, Yanling Yang, Zhongqi Mao, Yijun Mei, Huan Liu, Yi Miao. Roux-en-Y gastric bypass for Chinese type 2 diabetes mellitus patients with a BMI<28 kg/m2: a multi-institutional study[J]. The Journal of Biomedical Research, 2015, 29(2): 112-117. DOI: 10.7555/JBR.29.20140109 |
[7] | Sonali Ganguly, Hong Chang Tan, Phong Ching Lee, Kwang Wei Tham. Metabolic bariatric surgery and type 2 diabetes mellitus: an endocrinologist’ s perspective[J]. The Journal of Biomedical Research, 2015, 29(2): 105-111. DOI: 10.7555/JBR.29.20140127 |
[8] | Yong Xu. Transcriptional regulation of endothelial dysfunction in atherosclerosis: an epigenetic perspective[J]. The Journal of Biomedical Research, 2014, 28(1): 47-52. DOI: 10.7555/JBR.27.20130055 |
[9] | Ravi Prakash Rao, Ansima Singh, Arun K Jain, Bhartu Parsharthi Srinivasan. Dual therapy of rosiglitazone/pioglitazone with glimepiride on diabetic nephropathy in experimentally induced type 2 diabetes rats[J]. The Journal of Biomedical Research, 2011, 25(6): 411-417. DOI: 10.1016/S1674-8301(11)60054-7 |
[10] | Guanhua Su, Kun Liu, Yan Wang, Jue Wang, Xiaowei Li, Wenzhu Li, Yuhua Liao, Zhaohui Wang. Fibrinogen-like protein 2 expression correlates with microthrombosis in rats with type 2 diabetic nephropathy[J]. The Journal of Biomedical Research, 2011, 25(2): 120-127. DOI: 10.1016/S1674-8301(11)60015-8 |
1. | Jadhao AG, Gaikwad KB, Yadav RR. Serum retinol binding protein 4 in individuals with essential hypertension and type 2 diabetes: A cross-sectional study. J Family Med Prim Care, 2024, 13(9): 3748-3752. DOI:10.4103/jfmpc.jfmpc_57_24 |
2. | Yang S, Chen Q, Fan Y, et al. The essential role of dual-energy x-ray absorptiometry in the prediction of subclinical cardiovascular disease. Front Cardiovasc Med, 2024, 11: 1377299. DOI:10.3389/fcvm.2024.1377299 |
3. | Varadarajan V, Gidding SS, Wu C, et al. Imaging Early Life Cardiovascular Phenotype. Circ Res, 2023, 132(12): 1607-1627. DOI:10.1161/CIRCRESAHA.123.322054 |
4. | Jiménez-Cortegana C, Iglesias P, Ribalta J, et al. Nutrients and Dietary Approaches in Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease: A Narrative Review. Nutrients, 2021, 13(11): 4150. DOI:10.3390/nu13114150 |
5. | Lőrincz H, Csige I, Harangi M, et al. Low Levels of Serum Fetuin-A and Retinol-Binding Protein 4 Correlate with Lipoprotein Subfractions in Morbid Obese and Lean Non-Diabetic Subjects. Life (Basel), 2021, 11(9): 881. DOI:10.3390/life11090881 |
6. | Rychter AM, Skrzypczak-Zielińska M, Zielińska A, et al. Is the Retinol-Binding Protein 4 a Possible Risk Factor for Cardiovascular Diseases in Obesity?. Int J Mol Sci, 2020, 21(15): 5229. DOI:10.3390/ijms21155229 |
7. | Du X, Dong Y, Xiao L, et al. Association between retinol-binding protein 4 concentrations and gestational diabetes mellitus (A1GDM and A2GDM) in different pregnancy and postpartum periods. Ann Transl Med, 2019, 7(18): 479. DOI:10.21037/atm.2019.08.45 |
8. | Blaner WS. Vitamin A signaling and homeostasis in obesity, diabetes, and metabolic disorders. Pharmacol Ther, 2019, 197: 153-178. DOI:10.1016/j.pharmthera.2019.01.006 |
9. | Zhu YY, Zhang JL, Liu L, et al. Evaluation of serum retinol-binding protein-4 levels as a biomarker of poor short-term prognosis in ischemic stroke. Biosci Rep, 2018, 38(5): BSR20180786. DOI:10.1042/BSR20180786. Print 2018 Oct 31 |
10. | Tabak O, Simsek G, Erdenen F, et al. The relationship between circulating irisin, retinol binding protein-4, adiponectin and inflammatory mediators in patients with metabolic syndrome. Arch Endocrinol Metab, 2017, 61(6): 515-523. DOI:10.1590/2359-3997000000289 |
11. | Rubinow KB, Henderson CM, Robinson-Cohen C, et al. Kidney function is associated with an altered protein composition of high-density lipoprotein. Kidney Int, 2017, 92(6): 1526-1535. DOI:10.1016/j.kint.2017.05.020 |
12. | Tabesh M, Noroozi A, Amini M, et al. Association of retinol-binding protein 4 with metabolic syndrome in first-degree relatives of type 2 diabetic patients. J Res Med Sci, 2017, 22: 28. DOI:10.4103/1735-1995.200270 |